Gingival crevicular fluid level of soluble triggering recep-tor expressed on myeloid cells-1(strem-1) in periodontal health and disease: a case-control study

 
 
 
  • Abstract
  • Keywords
  • References
  • PDF
  • Abstract


    Background: The Triggering Receptor Expressed On Myeloid Cells-1(TREM-1) is a cell-surface receptor of the immunoglobulin superfamily and found to be involved in the amplification of the inflammatory response to various microbial infections, including periodontal diseases.

    Objectives: The present study was designed to examine gingivalcrevicular fluid(GCF) levels of soluble TREM-1 (sTREM-1) levels in periodontal health and disease as well as evaluate the effect of scaling and/or root planing on the same.

    Methods: Based on gingival index, probing pocket depth, clinical attachment level, and radiologic parameters (bone loss), 45 subjects were initially divided into three groups- Group, I (Periodontally healthy), Group II (Gingivitis) and Group III (Chronic Periodontitis).From each of the subjects, GCF sample was collected at baseline and scaling and/or root planing was instituted in group II and group III patients. GCF samples were subsequently collected at eight-week interval. Levels of sTREM-1 in collected GCF samples were estimated using enzyme-linked immunosorbent assay.

    Results: The lowest GCF levels of sTREM-1 were found in periodontal health (69.50±1.8pg/ml) followed by gingivitis (257.17±79pg/ml) and chronic periodontitis (3658.14±55pg/ml) in increasing order, suggesting that levels of sTREM-1 in crevicular fluid increased with the severity of periodontal disease. sTREM-1 levels decreased significantly from baseline to the end of 8 weeks following non-surgical periodontal therapy.

    Conclusion: Increased GCF levels of sTREM-1 from periodontal health to disease strengthen its association with periodontal status.


  • Keywords


    Chronic Periodontitis; Gingival Crevicularfluid; Gingivitis; Scaling and/or Root Planing; Triggering Receptor Expressed on Myeloid Cells-1

  • References


      [1] Anitha K, Balu P, Sakthidevi S, Kumar A. Biomarkers-A diagnostic tool for periodontal diseases. Journal of Scientific Dentistry 2013; 3: 59-65.

      [2] Bostanci N, Thurnheer T, Belibasakis GN. Involvement of the TREM-1/DAP12 pathway in the innate immune response to Porphyromonasgingivalis. MolImmunol 2011; 49:387-394. https://doi.org/10.1016/j.molimm.2011.09.012.

      [3] Bison C, Massin F, Lefevre PA, Thelly N, Miller N, Gibot S. Increased gingival crevicular fluid levels of soluble triggering receptor expressed on myeloid cells sTREM-1 in severe periodontitis. J ClinPeriodontol 2012; 39:1141-1148. https://doi.org/10.1111/jcpe.12008.

      [4] Bostanci N, Belibasakis GN. Doxycycline inhibits TREM-1 induction by Porphyromonasgingivalis. FEMS Immunol Med Microbiol2012; 66:37-44. https://doi.org/10.1111/j.1574-695X.2012.00982.x.

      [5] Bostanci N, Thurnheer T, Opoku J, Curtis MA, Zinkernagel AS, Belibasakis GN. Porphyromonasgingivalis regulates TREM-1 in human polymorphonuclear neutrophils via its gingipains. Plos One 2013; 8:1-8. https://doi.org/10.1371/journal.pone.0075784.

      [6] Lei L, Li H, Yan Fuhua, Xiao Y. Hyperlipidemia impaired innate immune response to periodontal pathogen Porphyromonasgingivalis in apolipoprotein E knockout mice. Plos One 2013; 88:1-9.

      [7] Willi M, Belibasakis GN, Bostanci N. Expression and regulation of TREM-1 in periodontal diseases. ClinExpImmunol 2014; 178:190-200. https://doi.org/10.1111/cei.12397.

      [8] Pradeep AR, Happy D, Parag H, Garima G, Manojkumar T. Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease. J Periodontol 2009; 80:1454-1461. https://doi.org/10.1902/jop.2009.090117.

      [9] Loe H. The gingival index, the plaque index and the retention index systems. J Periodontol1967; 38:610-616. https://doi.org/10.1902/jop.1967.38.6_part2.610.

      [10] Colonna M, Facchetti F. TREM-1(Treiggering Receptor Expressed on Myeloid Cells): a new player in acute inflammatory responses. JID 2003; 187(2):397-401. https://doi.org/10.1086/374754.

      [11] Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. CurrOpinImmunom 2009; 21 (1): 38-46. https://doi.org/10.1016/j.coi.2009.01.009.

      [12] BelibasakisGN,Ozturk VO, EmingilG,Bostanci N. Soluble triggering receptor expressed on myeloid cells (sTREM-1) in gingival crevicular fluid: Association with clinical and microbiological parameters. J periodontol 2014; 85:204-210. https://doi.org/10.1902/jop.2013.130144.

      [13] Bostanci N, Ozturk VO, Emingil G, Belibasakis GN. Elevated oral and systemic levels of soluble triggering receptor expressed on myeloid cells -1 in periodontitis. J Dent Res 2013; 92:161-165. https://doi.org/10.1177/0022034512470691.

      [14] Hammerle CHF, Joss A, Lang NP. Short term effects of initial periodontal therapy (hygienic phase). J ClinPeriodontol1991; 18: 233–239 https://doi.org/10.1111/j.1600-051X.1991.tb00420.x.

      [15] Cobb CM. Non-surgical pocket therapy: mechanical. Ann Periodontol 1996; 1:443-490. https://doi.org/10.1902/annals.1996.1.1.443.

      [16] Hill RW, Ramfjord SP, Morrison EC. Four types of periodontal treatment compared over two years. J Periodontol 1981; 52:655-662. https://doi.org/10.1902/jop.1981.52.11.655.

      [17] Kaldahl WB, Kalkwarf KL, Patil KD, Dyer JK, Bates RE Jr. Evaluation of four modalities of periodontal therapy. Mean probing depth, probing attachment level and recession changes. J Periodontol 1988; 59:783-793. https://doi.org/10.1902/jop.1988.59.12.783.

      [18] Veena HR, Prasad D. Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects. J Indian SocPeriodontol. 2010; 14: 40–45. https://doi.org/10.4103/0972-124X.65438.


 

View

Download

Article ID: 7689
 
DOI: 10.14419/ijdr.v5i2.7689




Copyright © 2012-2015 Science Publishing Corporation Inc. All rights reserved.